-
Je něco špatně v tomto záznamu ?
Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients
A. Kolek, J. Prasko, M. Ociskova, M. Holubova, J. Vanek, A. Grambal, M. Slepecky,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, metaanalýza
- MeSH
- antidepresiva terapeutické užití MeSH
- disociační poruchy komplikace epidemiologie terapie MeSH
- dítě MeSH
- dospělí MeSH
- hospitalizace statistika a číselné údaje MeSH
- hospitalizovaní pacienti MeSH
- kognitivně behaviorální terapie * MeSH
- kombinovaná terapie MeSH
- komorbidita MeSH
- léková rezistence * fyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nepříznivé zkušenosti z dětství * statistika a číselné údaje MeSH
- panická porucha diagnóza epidemiologie psychologie terapie MeSH
- poruchy osobnosti epidemiologie terapie MeSH
- sebepojetí MeSH
- společenské stigma MeSH
- stupeň závažnosti nemoci MeSH
- výsledek terapie MeSH
- vývoj dítěte fyziologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
OBJECTIVES: A combination of antidepressants with the cognitive-behavioural therapy showed effectiveness in treatment-resistant patients with panic disorder. This prospective study intended to establish how childhood adverse experiences, self-stigma, dissociation, and severity of psychopathology influence the effectiveness of combined cognitive-behavioural therapy and pharmacotherapy in patients with treatment-resistant panic disorder. METHODS: One hundred and ten patients were included into the study and one hundred five subjects finished the study. After admission, the subjects were assessed during the first two days of hospitalization. Rating scales were administered before the beginning of the cognitive behavioural therapy (measurement-1) and at the end of the treatment which was after six weeks (measurement-2). Patients with panic disorder were treated using a combination of group cognitive-behavioural therapy and antidepressants. The usual antidepressant dosage range was used. Before admission to intensive cognitive behavioural therapy program, the patients were unsuccessfully treated by antidepressants for minimum 3 months, which defined them as pharmacoresistant. RESULTS: Hospitalized pharmacoresistant patients with panic disorder improved significantly throughout the 6-week intensive CBT program in all measurements that assessed the overall severity of the disorder, the degree of general anxiety and depression and the severity of specific symptoms of panic disorder and agoraphobia. The rate of improvement was negatively related to sexual abuse in childhood, presence of comorbid personality disorder, and positively with the severity of the disorder at the beginning, and the level of self-stigma at the beginning of treatment. Improvement in symptoms correlates significantly with decreasing of dissociation during the treatment.severity of depressive symptoms. The earlier development of the disorder is linked to higher score in childhood adverse events, higher level of dissociation and pathological dissociation, and higher level of self-stigma. CONCLUSIONS: Our prospective study discovers importance of the role of adverse childhood experiences, self-stigma, dissociation and comorbid personality disorder in effectiveness of combined cognitive-behavioural therapy and pharmacotherapy treatment in patients with treatment-resistant panic disorder.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025450
- 003
- CZ-PrNML
- 005
- 20201222160223.0
- 007
- ta
- 008
- 201125s2019 sw f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)32200586
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Kolek, Antonín $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 245 10
- $a Severity of panic disorder, adverse events in childhood, dissociation, self-stigma and comorbid personality disorders Part 2: Therapeutic effectiveness of a combined cognitive behavioural therapy and pharmacotherapy in treatment-resistant inpatients / $c A. Kolek, J. Prasko, M. Ociskova, M. Holubova, J. Vanek, A. Grambal, M. Slepecky,
- 520 9_
- $a OBJECTIVES: A combination of antidepressants with the cognitive-behavioural therapy showed effectiveness in treatment-resistant patients with panic disorder. This prospective study intended to establish how childhood adverse experiences, self-stigma, dissociation, and severity of psychopathology influence the effectiveness of combined cognitive-behavioural therapy and pharmacotherapy in patients with treatment-resistant panic disorder. METHODS: One hundred and ten patients were included into the study and one hundred five subjects finished the study. After admission, the subjects were assessed during the first two days of hospitalization. Rating scales were administered before the beginning of the cognitive behavioural therapy (measurement-1) and at the end of the treatment which was after six weeks (measurement-2). Patients with panic disorder were treated using a combination of group cognitive-behavioural therapy and antidepressants. The usual antidepressant dosage range was used. Before admission to intensive cognitive behavioural therapy program, the patients were unsuccessfully treated by antidepressants for minimum 3 months, which defined them as pharmacoresistant. RESULTS: Hospitalized pharmacoresistant patients with panic disorder improved significantly throughout the 6-week intensive CBT program in all measurements that assessed the overall severity of the disorder, the degree of general anxiety and depression and the severity of specific symptoms of panic disorder and agoraphobia. The rate of improvement was negatively related to sexual abuse in childhood, presence of comorbid personality disorder, and positively with the severity of the disorder at the beginning, and the level of self-stigma at the beginning of treatment. Improvement in symptoms correlates significantly with decreasing of dissociation during the treatment.severity of depressive symptoms. The earlier development of the disorder is linked to higher score in childhood adverse events, higher level of dissociation and pathological dissociation, and higher level of self-stigma. CONCLUSIONS: Our prospective study discovers importance of the role of adverse childhood experiences, self-stigma, dissociation and comorbid personality disorder in effectiveness of combined cognitive-behavioural therapy and pharmacotherapy treatment in patients with treatment-resistant panic disorder.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a nepříznivé zkušenosti z dětství $x statistika a číselné údaje $7 D000076783
- 650 _2
- $a antidepresiva $x terapeutické užití $7 D000928
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a vývoj dítěte $x fyziologie $7 D002657
- 650 12
- $a kognitivně behaviorální terapie $7 D015928
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a komorbidita $7 D015897
- 650 _2
- $a disociační poruchy $x komplikace $x epidemiologie $x terapie $7 D004213
- 650 12
- $a léková rezistence $x fyziologie $7 D004351
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hospitalizace $x statistika a číselné údaje $7 D006760
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hospitalizovaní pacienti $7 D007297
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a panická porucha $x diagnóza $x epidemiologie $x psychologie $x terapie $7 D016584
- 650 _2
- $a poruchy osobnosti $x epidemiologie $x terapie $7 D010554
- 650 _2
- $a sebepojetí $7 D012649
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a společenské stigma $7 D057545
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 700 1_
- $a Prasko, Jan $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 700 1_
- $a Ociskova, Marie $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 700 1_
- $a Holubova, Michaela $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 700 1_
- $a Vanek, Jakub $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 700 1_
- $a Grambal, Ales $u Department of Psychiatry, Faculty of Medicine and Dentistry, University Palacky Olomouc, University Hospital, 77520 Olomouc, Czech Republic.
- 700 1_
- $a Slepecky, Milos $u Department of Psychology Sciences, Faculty of Social Science and Health Care, Constantine the Philosopher University in Nitra, Slovakia.
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 2354-4716 $g Roč. 40, č. 6 (2019), s. 271-283
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32200586 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160219 $b ABA008
- 999 __
- $a ok $b bmc $g 1599595 $s 1116136
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 40 $c 6 $d 271-283 $e - $i 2354-4716 $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20201125